5 Dividend Stocks Yielding Over 4% Retirees Should Buy Before December

Published November 21, 2026, 12:00pm ET · 6 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

An older Black man in a gray sweater and glasses and an older white woman in a blue shirt sit at a table, both intently focused on financial documents and a silver laptop. The man points at a paper he's holding, while the woman points at a document in front of the laptop. A white textured coffee mug is visible in the foreground.
An affluent couple reviews their financial documents, considering strategies like optimizing 401(k) withdrawals for retirement. © PeopleImages / Getty Images

Retirees heading into year-end need two things from an income stock: a yield that tops inflation and a payout the business can comfortably fund. A big headline yield can also be the market pricing in a cut, which is the whole subject of our free guide to the seven warning signs of a dividend trap. All five names below yield above 4% at the November 20 close, and each one passed a check of earnings coverage, cash flow, balance sheet and actual dividend history. Two names that are often on retiree lists were left out because their yields came in under 4% at current prices. The lead example is Verizon Communications (NYSE:VZ | VZ Price Prediction), whose $2.83 annualized dividend against a $46.53 share price works out to a 6.08% yield.

Company Nov. 20 Close Annualized Dividend Yield Coverage Check
Altria Group (NYSE:MO) $74.87 $4.44 5.93% About 78% of low-end 2026 adj. EPS guidance
Verizon $46.53 $2.83 6.08% About 56% of low-end 2026 adj. EPS guidance
Pfizer (NYSE:PFE) $27.43 $1.72 6.27% About 58% of low-end 2026 adj. EPS guidance
Enterprise Products Partners (NYSE:EPD) $35.83 $2.24 6.25% 1.9x distribution coverage in Q3
ONEOK (NYSE:OKE) $84.37 $4.28 5.07% About 68% of 2026 EPS guidance midpoint

Altria Group: 61 Raises in 57 Years and Still Growing

Altria is a high-yield name at 5.93%, based on its $4.44 annualized forward dividend. In August the board raised the quarterly payout 4.7% to $1.11 per share[1], which the CFO called "our 61st increase in 57 years." The dividend record backs that up: the quarterly rate rose from $0.94 in 2022 to $0.98, $1.02, $1.06 and now $1.11.

Dividend safety: The annual dividend uses about 78% of the low end of Altria’s raised 2026 adjusted EPS guidance of $5.66 to $5.74[2]. That’s a high payout, but it matches the company’s deliberate policy of returning most of its earnings. Leverage is under control, with debt-to-EBITDA at 1.9x[1] against a target of about 2x. Over the first nine months, Altria paid $5.3 billion[1] in dividends and still had room for $735 million of buybacks. Shareholders’ equity is negative at -$2.225 billion[2]. That comes from years of buybacks and doesn’t show distress.

Bull case: Cigarettes still produce huge margins. The smokeable segment posted a 64.5%[2] adjusted operating companies income margin, and Marlboro grew its share of the premium segment to 60%[1]. Management is targeting mid-single-digit annual dividend growth through 2028. Timing matters here: last year Altria declared its dividend on December 10, 2025, with a December 26, 2025 ex-dividend date.

Risk: Cigarette volumes keep shrinking. Adjusted domestic volumes fell an estimated 4%[1], and on! nicotine pouch retail share slipped 0.3[1] points from the prior quarter to 8.3%. The stock is also up 36.15% year to date, so the yield is lower than it was in January.

Verizon: Ultra-High-Yield Backed by Rising Free Cash Flow

Verizon yields 6.08%, which puts it in ultra-high-yield territory. It is also one of the best-covered payouts on this list.

Dividend safety: The $2.83 annual dividend equals about 56% of the low end of 2026 adjusted EPS guidance of $5.04 to $5.06[3], which management has raised for three straight quarters. Third-quarter free cash flow reached $7.801 billion[3], up 13.9% from a year earlier, and full-year free cash flow growth is guided to about 12%. The payment record shows a raise every year, from $0.50 a quarter in 2011 to 2012 up to $0.7075 today. Verizon is also buying back up to $4.5 billion[3] of stock this year, with $4.0 billion completed through the first nine months.

Here is the case for Verizon: The subscriber turnaround under CEO Dan Schulman is showing up in the numbers. Verizon added 406K[3] postpaid phone subscribers in the quarter, compared with 44K a year ago, plus 314K broadband customers. Adjusted EBITDA margin rose to 40.2%[3] from 37.8%. Shares have gained 21.89% year to date, and the yield is still above 6%. Last year’s first-quarter dividend was declared on December 4, 2025.

Risk: Verizon carries a lot of debt. Total debt stands at $166.2 billion[3], interest expense rose 17.2% year over year, and net unsecured debt to adjusted EBITDA increased to 2.5x[4] from 2.2x at the end of 2025.

Pfizer: Highest Yield on the List, Dividend Held Flat for 2026

Pfizer has the highest yield here at 6.27%. The quarterly dividend has stayed at $0.43 all year, after an increase from $0.42 in 2025. Shareholders are due to be paid December 7, 2026.

Dividend safety: Earnings cover the payout. The $1.72 annual dividend is about 58% of the low end of raised 2026 adjusted EPS guidance of $2.95 to $3.05[5]. Third-quarter operating cash flow was $8.8 billion[6], and leverage of 2.6 times came in under the company’s 2.7 times target. Free cash flow is less comfortable: the trailing free cash flow yield of 5.81% is below the dividend yield, which is one reason buybacks remain on hold. Per the CFO, "Through the LOE period, our operating cash flow, financial assets, and access to capital markets will give us the ability to continue to invest and maintain the dividend."[6]

Bull case: Sales outside COVID products grew 7%[5] operationally, and launched and acquired products grew 32%. Eliquis reached $2.523 billion[5] (up 25%) and Padcev reached $720 million (up 55%). The stock trades at about 20 times earnings.

Risk: Patent expirations are coming for Ibrance, Xtandi, and Eliquis internationally at the end of 2026[6], and management expects leverage to stay near current levels "or modestly higher" during that stretch. The share price is down 29.26% over five years, and income investors should expect the dividend to stay flat for now.

Enterprise Products Partners: 1.9x Coverage at an Ultra-High Yield

Enterprise yields 6.25% on its $2.24 annualized distribution. Of the five, it has the widest safety margin.

Dividend safety: Third-quarter operating distributable cash flow rose 27% to $2.3 billion, covering the distribution 1.9 times and leaving $1.1 billion for growth projects, buybacks and debt reduction. The quarterly distribution has risen steadily from $0.45 in 2021 to $0.56, and the partnership closed 2025 with its 27th consecutive year of distribution growth.

Bull case: Permian Basin processing volumes hit a record 4.6 Bcf/d, and Enterprise has $6.3 billion of growth projects under construction through 2028. Two of them are due in the fourth quarter: a Houston Ship Channel LPG terminal expansion to 1.1 MMBPD and the 300 MMcf/d Athena processing plant. Most revenue comes from fees, so cash flow is less linked to commodity prices than at an oil producer.

Risk: Enterprise is a partnership, so investors receive a Schedule K-1 instead of a 1099, which can complicate taxes in IRAs. It also reported lower Midland Basin processing margins and a $13 million mark-to-market hedging loss in the quarter.

ONEOK: Higher-Rated Balance Sheet Behind a High-Yield Payout

ONEOK rounds out the list as a high-yield name at 5.07%. The quarterly dividend is $1.07 after a 4% raise in January 2026.

Dividend safety: The $4.28 annual dividend is about 68% of the raised 2026 EPS guidance midpoint of $6.30. The balance sheet improved this fall. ONEOK paid off about $5.5 billion of debt principal in September 2026, and S&P and Fitch raised its credit rating to BBB+. The dividend record shows no cut since 2020. The payout stayed at $0.935 from 2020 through 2022 and has risen every year since.

The case for ONEOK: Third-quarter adjusted EBITDA rose 6% to $2.24 billion on record Permian volumes, and the full-year EBITDA midpoint went up to $8.55 billion. The CEO said, "As we look to 2027, we expect meaningful earnings growth from our Brazos Permian Midland Basin assets, recently completed and advancing growth projects and continued commercial optimization across our systems." ONEOK raised its dividend in January 2026, so the next decision is likely around the turn of the year.

Risk: Third-quarter GAAP EPS of $2.13 included a one-time tax benefit of $0.53 per share, so underlying coverage is tighter than the headline ratio suggests. Cash on hand was only $186 million, and the shares fell 2.4850% on November 20.

Five Payouts Built to Hold Through 2027

Altria, Verizon, Pfizer, Enterprise and ONEOK all yield above 4% at current prices, and each pays its dividend out of earnings or distributable cash flow that covers the current rate. Enterprise’s 1.9x coverage and Verizon’s payout of about 56% are the strongest. Altria has the longest record of raises. Pfizer has the most to prove as its patent expirations hit. The next things to watch are the December and January dividend declarations and Pfizer’s 2027 guidance, which management said will account for MFN and IRA pricing.

Contact [email protected] for any questions or corrections.

Lee Jackson

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.

Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.

Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

All articles →

Sources

  1. Altria Group, Inc. Q3 2026 earnings callAltria Group, Inc.
  2. Altria Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  3. Verizon Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  4. Verizon Form 8-K (Q2 FY2026)U.S. Securities and Exchange Commission
  5. Pfizer Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  6. Pfizer, Inc. Q3 2026 earnings callPfizer, Inc.